SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

Investors are sharply divided over a tokenized crypto asset claiming to represent SpaceX shares, with many warning it is a deceptive scheme unrelated to the company. While the community remains highly skeptical of these digital tokens, genuine excitement is building around the anticipated public listing of the space giant, sparking intense debate over valuations, sector competition, and the risks of falling for speculative pre-IPO hype.

Baron ETF Trust - Baron First Principles ETF

The Baron First Principles ETF is actively trending as retail investors seek accessible, direct exposure to SpaceX ahead of a potential IPO. Community discussion is heavily focused on the fund's unique holding of common shares compared to other private equity vehicles, though some investors are debating potential dilution risks as the ETF's assets grow.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT) is attracting significant community attention due to its ongoing role in enterprise-level institutional projects and its reputation as a utility-focused asset, with many investors actively accumulating tokens during market volatility. Holders remain focused on its limited supply and the potential for institutional adoption in the banking sector, keeping sentiment bullish despite wider crypto market fluctuations.

Investment Managers Series Trust II - Tradr 2X Long AAOI Daily ETF

The Tradr 2X Long AAOI Daily ETF

AAOX is generating intense community interest as a leveraged vehicle for tracking the volatile price swings of Applied Optoelectronics within the optical networking and AI infrastructure sector. Traders are actively debating entry and exit points, focusing on the ETF's aggressive daily multipliers while cautioning one another about the inherent risks of holding leveraged positions during periods of high market fluctuation.

XYO is the original and one of the largest Decentralized Physical Infrastructure Networks (DePIN), boasting over 10 million nodes and consistently leading DePIN in both scale and revenue generation. Launching its Mainnet ahead of any other DePIN, XYO specializes in collecting and validating real-world data, bridging it seamlessly to Web3 and Web2 companies across AI, geolocation, and other critical data sectors. At the core of XYO are Proof of Location and Proof of Origin technologies, enabling accurate validation of real-world data for innovative use cases such as Real-World Asset (RWA) tracking, DePIN applications, real-world gaming, and treasure hunts. Recently, XYO expanded its ecosystem by launching the XYO Layer One blockchain, purpose-built to support the intensive data demands of DePIN, RWA, AI, and similar data-driven industries. XYO employs a unique dual-token model: XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases. The dual-token economics are strategically designed to increase scarcity and promote sustainable growth. The XYO token is available on major exchanges, including Coinbase. The XL1 token will launch publicly later in 2025. To accelerate network adoption and growth, XYO created the popular COIN app. Beyond the XYO Foundation, the team founded the U.S.-based, for-profit entity XY Labs Inc., notable as the first U.S. crypto company qualified by the SEC for a Regulation A offering, permitting share sales to both accredited and non-accredited investors. XY Labs further stands out as one of the pioneering U.S. companies to tokenize and publicly list its shares. These tokenized shares trade as $XYLB on the tZERO ATS, positioning XY Labs prominently in the growing wave of Real-World Asset (RWA) tokenization.

XYO Network

XYO Network is trending as the community debates its long-term viability, with vocal investors expressing frustration over repeated price retracements and perceived lack of major institutional news, while others remain optimistic about its underlying DePin technology and future potential. The active discussion is heavily polarized, featuring a mix of traders calling out pump-and-dump patterns and long-term believers who are aggressively accumulating during market dips.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as the community debates its long-term viability amid stagnant price action and anticipation surrounding the CLARITY Act's impact on crypto payment regulation. While some investors are aggressively accumulating tokens on the expectation of institutional adoption, others express deep frustration over the lack of transparency, declining market value, and the project's perceived inability to move in lockstep with the broader market.

Unleash Jugs

JUGS is gaining momentum as a newly launched meme-themed cryptocurrency, with community members highlighting its potential for rapid price volatility due to high token concentration among top holders. Investors are actively discussing the coin's early-stage growth and speculative appeal, frequently referencing its concentrated supply as a catalyst for potential short-term spikes.

KAT is a defi token with governance-like mechanics for Katana.  It is designed to function as a lever for directing capital: users that lock KAT receive a voting version of KAT — vKAT — in return. vKAT underpins key aspects of the chain’s economy, providing rewards to those users that participate. these fee-based rewards function as an incentive for KAT holders to engage in cooperative, positive-sum behavior.

Katana

Katana is trending as traders debate the potential for a price reversal following a period of high volatility and aggressive accumulation by community members. While some investors view recent price action as a strategic buying opportunity for long-term growth, others express caution, citing concerns over market manipulation and the project's long-term sustainability.

ARK ETF Trust - ARK Autonomous Technology & Robotics ETF

ARK Autonomous Technology & Robotics ETF

ARKQ is capturing community attention as investors debate its role in the robotics and autonomous technology sector, with many discussing its correlation to the performance of top holdings like Tesla. While some traders express caution over volatility and Cathie Wood's investment style, others view the fund as a long-term play on AI-driven industrial transformation.

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.

Tango Therapeutics Inc

Tango Therapeutics is trending as investors digest significant clinical trial developments and a recent capital raise aimed at accelerating its late-stage development of vopimetostat. The community is actively discussing the company's oncology pipeline potential, particularly its collaborations and synthetic lethality approach, while navigating sentiment shifts fueled by volatility in the biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance under the companys Investigational...

CPRX or UTHR: Which Is the Better Value Stock Right Now?

CPRX vs. UTHR: Which Stock Is the Better Value Option?

Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease

Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease Varda Space Industries and United Therapeutics Collaborate to Advance...

United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide a company overview and update on Tuesday, May 19, 2026, from...

United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that 12 new data presentations across its commercial and development portfolio will be presented at the...

UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook 

United Therapeutics shares rise after Q1 earnings miss estimates as investors focus on Tyvaso IPF data and ralinepag's blockbuster potential.

United Therapeutics (NASDAQ:UTHR) Announces Earnings Results, Misses Expectations By $1.18 EPS

United Therapeutics (NASDAQ:UTHR - Get Free Report) posted its quarterly earnings results on Wednesday. The biotechnology company reported $5.82 earnings per share for the quarter, missing the consensus estimate of $7.00 by ($1.18). The business had revenue of $781.50 million during the quarter...

MNKD Stock Records Biggest Single-Day Gains In Over 5 Years, Breaches A Key Technical Milestone – What’s Driving This Rally?

MannKind is developing a dry powder inhalation version of a drug to treat pulmonary arterial hypertension.

Equity

Biotech Stocks To Add to Your Watchlist - May 6th

Danaher, Avalo Therapeutics, Vertex Pharmaceuticals, United Therapeutics, argenex, ImmunityBio, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that use biological science and technology t...

Transcript: United Therapeutics Q1 2026 Earnings Conference Call

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Current Price	$568.58
Prev Close	$575.79
Open	$576.49
Dividend Yield	0.00%
50-Day Moving Average	$560.11
Beta	0.44
Avg. Volume	470,504.76
PE Ratio	20.98

52-Week High	$609.35
52-Week Low	$272.12
Market Capitalization	$24.13B
EPS (Annual)	$27.86
Price to Book	4.06
Revenue Per Employee	$2.27M

UTHR
United Therapeutics Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UTHR News

UTHRUnited Therapeutics Corp